Actionable news
0
All posts from Actionable news
Actionable news in ACOR: Acorda Therapeutics, Inc.,

Acorda Therapeutics Inc.

GO

Average Recommendation: Overweight Average Target Price: 43.71
Number of Ratings: 9 Current Quarters Estimate: -0.12
FY Report Date: 12 / 2015 Current Year's Estimate: -0.08
Last Quarter's Earnings: 0.09 Median PE on CY...

More